Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 82 entries
Sorted by: Best Match Show Resources per page
A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization.

Hepatology research : the official journal of the Japan Society of Hepatology

Suzuki M, Maeyama S, Okuse N, Nishikawa K, Kobayashi Y, Takahashi Y, Okuse C, Osada T, Hayashi T, Yotuyanagi H, Takatori M, Ogata S, Uchikoshi T, Iino S.
PMID: 11804837
Hepatol Res. 2002 Jan;22(1):74-82. doi: 10.1016/s1386-6346(01)00117-6.

The patient was a 49-year-old male under observation for chronic hepatitis B. In July 1997, abdominal ultrasonography showed multiple hyperechoic nodules in the right lobe, the largest with a diameter of 3.5 cm. Abdominal computed tomography did not reveal...

Cite
Suzuki M, Maeyama S, Okuse N, et al. A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. Hepatol Res. 2002;22(1):74-82doi: 10.1016/s1386-6346(01)00117-6.
Suzuki, M., Maeyama, S., Okuse, N., Nishikawa, K., Kobayashi, Y., Takahashi, Y., Okuse, C., Osada, T., Hayashi, T., Yotuyanagi, H., Takatori, M., Ogata, S., Uchikoshi, T., & Iino, S. (2002). A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. Hepatology research : the official journal of the Japan Society of Hepatology, 22(1), 74-82. https://doi.org/10.1016/s1386-6346(01)00117-6
Suzuki, Michihiro, et al. "A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization." Hepatology research : the official journal of the Japan Society of Hepatology vol. 22,1 (2002): 74-82. doi: https://doi.org/10.1016/s1386-6346(01)00117-6
Suzuki M, Maeyama S, Okuse N, Nishikawa K, Kobayashi Y, Takahashi Y, Okuse C, Osada T, Hayashi T, Yotuyanagi H, Takatori M, Ogata S, Uchikoshi T, Iino S. A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. Hepatol Res. 2002 Jan;22(1):74-82. doi: 10.1016/s1386-6346(01)00117-6. PMID: 11804837.
Copy Download .nbib Format: NLM
Hepatitis viral infection in Behçet's disease.

Hepatology research : the official journal of the Japan Society of Hepatology

Akaogi J, Yotsuyanagi H, Sugata F, Matsuda T, Hino K.
PMID: 10707006
Hepatol Res. 2000 May;17(2):126-138. doi: 10.1016/s1386-6346(99)00070-4.

To elucidate the role of hepatitis viruses in the pathogenesis of Behçet's disease (BD), we measured hepatitis viral markers (anti-hepatitis A (anti-HA), HBsAg, anti-HBs, anti-HBc) and viral nucleic acids (hepatitis B virus (HBV)-DNA, hepatitis C virus (HCV)-RNA, GB virus...

Cite
Akaogi J, Yotsuyanagi H, Sugata F, et al. Hepatitis viral infection in Behçet's disease. Hepatol Res. 2000;17(2):126-138doi: 10.1016/s1386-6346(99)00070-4.
Akaogi, J., Yotsuyanagi, H., Sugata, F., Matsuda, T., & Hino, K. (2000). Hepatitis viral infection in Behçet's disease. Hepatology research : the official journal of the Japan Society of Hepatology, 17(2), 126-138. https://doi.org/10.1016/s1386-6346(99)00070-4
Akaogi, et al. "Hepatitis viral infection in Behçet's disease." Hepatology research : the official journal of the Japan Society of Hepatology vol. 17,2 (2000): 126-138. doi: https://doi.org/10.1016/s1386-6346(99)00070-4
Akaogi J, Yotsuyanagi H, Sugata F, Matsuda T, Hino K. Hepatitis viral infection in Behçet's disease. Hepatol Res. 2000 May;17(2):126-138. doi: 10.1016/s1386-6346(99)00070-4. PMID: 10707006.
Copy Download .nbib Format: NLM
Aromatic polyaminocarboxylate ligands for energy transfer luminescence measurements of lanthanide ions in aqueous solutions.

Talanta

Hoshino H, Utsumi SY, Yotsuyanagi T.
PMID: 18965892
Talanta. 1994 Jan;41(1):93-8. doi: 10.1016/0039-9140(94)80173-8.

The promising ligand candidates for the energy transfer luminescence measurements of lanthanide (Ln) chelates on aqueous matrices are first proposed. The ligands are; 2[(2-amino-5-methyl-phenoxy)methyl]-6-methoxy-8-aminoquinoline-N,N,N',N'-tetraacetate (Quin 2), 1,2-bis(2-amino-phenoxy)ethane-N,N,N',N'-tetraacetate (BAPTA), and 1,2-bis(2-amino-5-fluoro-phenoxy)ethane-N,N,N',N'-tetraacetate (F-BAPTA). The Ln-chelates of these aromatic polyaminocarboxylates show the...

Cite
Hoshino H, Utsumi SY, Yotsuyanagi T. Aromatic polyaminocarboxylate ligands for energy transfer luminescence measurements of lanthanide ions in aqueous solutions. Talanta. 1994;41(1):93-8doi: 10.1016/0039-9140(94)80173-8.
Hoshino, H., Utsumi, S. Y., & Yotsuyanagi, T. (1994). Aromatic polyaminocarboxylate ligands for energy transfer luminescence measurements of lanthanide ions in aqueous solutions. Talanta, 41(1), 93-8. https://doi.org/10.1016/0039-9140(94)80173-8
Hoshino, H, et al. "Aromatic polyaminocarboxylate ligands for energy transfer luminescence measurements of lanthanide ions in aqueous solutions." Talanta vol. 41,1 (1994): 93-8. doi: https://doi.org/10.1016/0039-9140(94)80173-8
Hoshino H, Utsumi SY, Yotsuyanagi T. Aromatic polyaminocarboxylate ligands for energy transfer luminescence measurements of lanthanide ions in aqueous solutions. Talanta. 1994 Jan;41(1):93-8. doi: 10.1016/0039-9140(94)80173-8. PMID: 18965892.
Copy Download .nbib Format: NLM
An ion-pair reversed-phase HPLC-fluorimetric system for ultratrace determination of aluminium with salicylaldehydebenzoylhydrazone.

Talanta

Uehara N, Kanbayashi M, Hoshino H, Yotsuyanagi T.
PMID: 18964857
Talanta. 1989 Oct;36(10):1031-5. doi: 10.1016/0039-9140(89)80188-2.

An ion-pair HPLC fluorimetric determination of Al(III) at trace level has been developed, with salicylaldehydebenzoylhydrazone (SAB) as a precolumn reagent. The highly fluorescent AlSAB chelate (lambda(ex) 390.8 nm, lambda(em) 458.1 nm) is separated on a LiChroCART RP-18 column with...

Cite
Uehara N, Kanbayashi M, Hoshino H, et al. An ion-pair reversed-phase HPLC-fluorimetric system for ultratrace determination of aluminium with salicylaldehydebenzoylhydrazone. Talanta. 1989;36(10):1031-5doi: 10.1016/0039-9140(89)80188-2.
Uehara, N., Kanbayashi, M., Hoshino, H., & Yotsuyanagi, T. (1989). An ion-pair reversed-phase HPLC-fluorimetric system for ultratrace determination of aluminium with salicylaldehydebenzoylhydrazone. Talanta, 36(10), 1031-5. https://doi.org/10.1016/0039-9140(89)80188-2
Uehara, N, et al. "An ion-pair reversed-phase HPLC-fluorimetric system for ultratrace determination of aluminium with salicylaldehydebenzoylhydrazone." Talanta vol. 36,10 (1989): 1031-5. doi: https://doi.org/10.1016/0039-9140(89)80188-2
Uehara N, Kanbayashi M, Hoshino H, Yotsuyanagi T. An ion-pair reversed-phase HPLC-fluorimetric system for ultratrace determination of aluminium with salicylaldehydebenzoylhydrazone. Talanta. 1989 Oct;36(10):1031-5. doi: 10.1016/0039-9140(89)80188-2. PMID: 18964857.
Copy Download .nbib Format: NLM
Dynamics of two-sign point vortices in positive and negative temperature states.

Physical review letters

Yatsuyanagi Y, Kiwamoto Y, Tomita H, Sano MM, Yoshida T, Ebisuzaki T.
PMID: 15783647
Phys Rev Lett. 2005 Feb 11;94(5):054502. doi: 10.1103/PhysRevLett.94.054502. Epub 2005 Feb 07.

Dynamics of two-sign point vortices in two-dimensional circular boundary is examined by numerical simulations with MDGRAPE-2. The vortex system is characterized by the inverse temperature beta as determined from the density of states of the microcanonical ensemble of numerically...

Cite
Yatsuyanagi Y, Kiwamoto Y, Tomita H, et al. Dynamics of two-sign point vortices in positive and negative temperature states. Phys Rev Lett. 2005;94(5):054502doi: 10.1103/PhysRevLett.94.054502.
Yatsuyanagi, Y., Kiwamoto, Y., Tomita, H., Sano, M. M., Yoshida, T., & Ebisuzaki, T. (2005). Dynamics of two-sign point vortices in positive and negative temperature states. Physical review letters, 94(5), 054502. https://doi.org/10.1103/PhysRevLett.94.054502
Yatsuyanagi, Yuichi, et al. "Dynamics of two-sign point vortices in positive and negative temperature states." Physical review letters vol. 94,5 (2005): 054502. doi: https://doi.org/10.1103/PhysRevLett.94.054502
Yatsuyanagi Y, Kiwamoto Y, Tomita H, Sano MM, Yoshida T, Ebisuzaki T. Dynamics of two-sign point vortices in positive and negative temperature states. Phys Rev Lett. 2005 Feb 11;94(5):054502. doi: 10.1103/PhysRevLett.94.054502. Epub 2005 Feb 07. PMID: 15783647.
Copy Download .nbib Format: NLM
Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus.

Hepatology research : the official journal of the Japan Society of Hepatology

Nagase Y, Yotsuyanagi H, Okuse C, Yasuda K, Kato T, Koike K, Suzuki M, Nishioka K, Iino S, Itoh F.
PMID: 17825061
Hepatol Res. 2008 Mar;38(3):252-8. doi: 10.1111/j.1872-034X.2007.00257.x. Epub 2007 Sep 06.

AIM: Nearly 20% of chronic hepatitis C (CHC) patients with genotype 2 hepatitis C virus (HCV) infection are not curable, even by interferon (IFN)-ribavirin combination therapy. The aim of this study is to investigate the factors that determine the...

Cite
Nagase Y, Yotsuyanagi H, Okuse C, et al. Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus. Hepatol Res. 2007;38(3):252-8doi: 10.1111/j.1872-034X.2007.00257.x.
Nagase, Y., Yotsuyanagi, H., Okuse, C., Yasuda, K., Kato, T., Koike, K., Suzuki, M., Nishioka, K., Iino, S., & Itoh, F. (2008). Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus. Hepatology research : the official journal of the Japan Society of Hepatology, 38(3), 252-8. https://doi.org/10.1111/j.1872-034X.2007.00257.x
Nagase, Yoshihiko, et al. "Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus." Hepatology research : the official journal of the Japan Society of Hepatology vol. 38,3 (2008): 252-8. doi: https://doi.org/10.1111/j.1872-034X.2007.00257.x
Nagase Y, Yotsuyanagi H, Okuse C, Yasuda K, Kato T, Koike K, Suzuki M, Nishioka K, Iino S, Itoh F. Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virus. Hepatol Res. 2008 Mar;38(3):252-8. doi: 10.1111/j.1872-034X.2007.00257.x. Epub 2007 Sep 06. PMID: 17825061.
Copy Download .nbib Format: NLM
Effects of discreteness on gauge glass models in two and three dimensions.

Physical review. E, Statistical, nonlinear, and soft matter physics

Yotsuyanagi S, Suemitsu Y, Ozeki Y.
PMID: 19518204
Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Apr;79(4):041138. doi: 10.1103/PhysRevE.79.041138. Epub 2009 Apr 23.

The q-state clock gauge glass model is studied to see the effect of discreteness on the Kosterlitz-Thouless (KT) transition and the ferromagnetic (FM) critical phenomenon in random systems. The nonequilibrium relaxation analysis is applied. In two dimensions, the successive...

Cite
Yotsuyanagi S, Suemitsu Y, Ozeki Y. Effects of discreteness on gauge glass models in two and three dimensions. Phys Rev E Stat Nonlin Soft Matter Phys. 2009;79(4):041138doi: 10.1103/PhysRevE.79.041138.
Yotsuyanagi, S., Suemitsu, Y., & Ozeki, Y. (2009). Effects of discreteness on gauge glass models in two and three dimensions. Physical review. E, Statistical, nonlinear, and soft matter physics, 79(4), 041138. https://doi.org/10.1103/PhysRevE.79.041138
Yotsuyanagi, Satoshi, et al. "Effects of discreteness on gauge glass models in two and three dimensions." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 79,4 (2009): 041138. doi: https://doi.org/10.1103/PhysRevE.79.041138
Yotsuyanagi S, Suemitsu Y, Ozeki Y. Effects of discreteness on gauge glass models in two and three dimensions. Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Apr;79(4):041138. doi: 10.1103/PhysRevE.79.041138. Epub 2009 Apr 23. PMID: 19518204.
Copy Download .nbib Format: NLM
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan.

Hepatology research : the official journal of the Japan Society of Hepatology

Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y.
PMID: 20156296
Hepatol Res. 2010 Jan;40(1):8-13. doi: 10.1111/j.1872-034X.2009.00634.x.

In the 2008 guidelines for the treatment of patients with chronic hepatitis C, pegylated interferon (Peg-IFN) combined with ribavirin for 48 weeks are indicated for treatment-naive patients infected with hepatitis C virus (HCV) of genotype 1. Treatment is continued...

Cite
Kumada H, Okanoue T, Onji M, et al. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res. 2010;40(1):8-13doi: 10.1111/j.1872-034X.2009.00634.x.
Kumada, H., Okanoue, T., Onji, M., Moriwaki, H., Izumi, N., Tanaka, E., Chayama, K., Sakisaka, S., Takehara, T., Oketani, M., Suzuki, F., Toyota, J., Nomura, H., Yoshioka, K., Seike, M., Yotsuyanagi, H., Ueno, Y. (2010). Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatology research : the official journal of the Japan Society of Hepatology, 40(1), 8-13. https://doi.org/10.1111/j.1872-034X.2009.00634.x
Kumada, Hiromitsu, et al. "Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan." Hepatology research : the official journal of the Japan Society of Hepatology vol. 40,1 (2010): 8-13. doi: https://doi.org/10.1111/j.1872-034X.2009.00634.x
Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res. 2010 Jan;40(1):8-13. doi: 10.1111/j.1872-034X.2009.00634.x. PMID: 20156296.
Copy Download .nbib Format: NLM
Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C.

Hepatology research : the official journal of the Japan Society of Hepatology

Chayama K, Hayes CN, Yoshioka K, Moriwaki H, Okanoue T, Sakisaka S, Takehara T, Oketani M, Toyota J, Izumi N, Hiasa Y, Matsumoto A, Nomura H, Seike M, Ueno Y, Yotsuyanagi H, Kumada H.
PMID: 21040273
Hepatol Res. 2010 Dec;40(12):1155-67. doi: 10.1111/j.1872-034X.2010.00726.x. Epub 2010 Oct 07.

AIM:   Several host and viral factors have been reported to influence the effectiveness of pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. In Japan, where the age of treated patients is comparatively high, recent studies have reported...

Cite
Chayama K, Hayes CN, Yoshioka K, et al. Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C. Hepatol Res. 2010;40(12):1155-67doi: 10.1111/j.1872-034X.2010.00726.x.
Chayama, K., Hayes, C. N., Yoshioka, K., Moriwaki, H., Okanoue, T., Sakisaka, S., Takehara, T., Oketani, M., Toyota, J., Izumi, N., Hiasa, Y., Matsumoto, A., Nomura, H., Seike, M., Ueno, Y., Yotsuyanagi, H., & Kumada, H. (2010). Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology, 40(12), 1155-67. https://doi.org/10.1111/j.1872-034X.2010.00726.x
Chayama, Kazuaki, et al. "Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C." Hepatology research : the official journal of the Japan Society of Hepatology vol. 40,12 (2010): 1155-67. doi: https://doi.org/10.1111/j.1872-034X.2010.00726.x
Chayama K, Hayes CN, Yoshioka K, Moriwaki H, Okanoue T, Sakisaka S, Takehara T, Oketani M, Toyota J, Izumi N, Hiasa Y, Matsumoto A, Nomura H, Seike M, Ueno Y, Yotsuyanagi H, Kumada H. Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C. Hepatol Res. 2010 Dec;40(12):1155-67. doi: 10.1111/j.1872-034X.2010.00726.x. Epub 2010 Oct 07. PMID: 21040273.
Copy Download .nbib Format: NLM
Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B.

Hepatology research : the official journal of the Japan Society of Hepatology

Ikeda K, Izumi N, Tanaka E, Yotsuyanagi H, Takahashi Y, Fukushima J, Kondo F, Fukusato T, Koike K, Hayashi N, Kumada H.
PMID: 23131000
Hepatol Res. 2013 Jun;43(6):596-604. doi: 10.1111/j.1872-034X.2012.01115.x. Epub 2012 Nov 07.

AIM: In order to evaluate and judge a fibrotic stage of patients with chronic hepatitis B, multivariate regression analysis was performed using multiple fibrosis markers.METHOD: A total of 227 patients from seven hepatology units and institutes were diagnosed by...

Cite
Ikeda K, Izumi N, Tanaka E, et al. Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B. Hepatol Res. 2012;43(6):596-604doi: 10.1111/j.1872-034X.2012.01115.x.
Ikeda, K., Izumi, N., Tanaka, E., Yotsuyanagi, H., Takahashi, Y., Fukushima, J., Kondo, F., Fukusato, T., Koike, K., Hayashi, N., & Kumada, H. (2013). Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B. Hepatology research : the official journal of the Japan Society of Hepatology, 43(6), 596-604. https://doi.org/10.1111/j.1872-034X.2012.01115.x
Ikeda, Kenji, et al. "Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B." Hepatology research : the official journal of the Japan Society of Hepatology vol. 43,6 (2013): 596-604. doi: https://doi.org/10.1111/j.1872-034X.2012.01115.x
Ikeda K, Izumi N, Tanaka E, Yotsuyanagi H, Takahashi Y, Fukushima J, Kondo F, Fukusato T, Koike K, Hayashi N, Kumada H. Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B. Hepatol Res. 2013 Jun;43(6):596-604. doi: 10.1111/j.1872-034X.2012.01115.x. Epub 2012 Nov 07. PMID: 23131000.
Copy Download .nbib Format: NLM
Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV.

Journal of medical virology

Adachi E, Saito M, Nagai H, Ikeuchi K, Koga M, Tsutsumi T, Yotsuyanagi H.
PMID: 34978090
J Med Virol. 2022 Jan 02; doi: 10.1002/jmv.27543. Epub 2022 Jan 02.

The cellular immune deficiency seen in people living with HIV (PLWH) is of potential concern as dysfunctional immune responses contribute to disease progression and dysregulated T cell responses can result in immunopathology. This article is protected by copyright. All...

Cite
Adachi E, Saito M, Nagai H, et al. Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV. J Med Virol. 2022;doi: 10.1002/jmv.27543.
Adachi, E., Saito, M., Nagai, H., Ikeuchi, K., Koga, M., Tsutsumi, T., & Yotsuyanagi, H. (2022). Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV. Journal of medical virology, . https://doi.org/10.1002/jmv.27543
Adachi, Eisuke, et al. "Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV." Journal of medical virology vol. (2022). doi: https://doi.org/10.1002/jmv.27543
Adachi E, Saito M, Nagai H, Ikeuchi K, Koga M, Tsutsumi T, Yotsuyanagi H. Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV. J Med Virol. 2022 Jan 02; doi: 10.1002/jmv.27543. Epub 2022 Jan 02. PMID: 34978090.
Copy Download .nbib Format: NLM
The Laterally Extended Paramedian Forehead Flap for Nasal Reconstruction: The Delay Technique Revisited.

Plastic and reconstructive surgery. Global open

Itani Y, Yotsuyanagi T, Yamauchi M, Sugai A, Kato S, Yamashita K, Isogai N.
PMID: 32766039
Plast Reconstr Surg Glob Open. 2020 Jun 15;8(6):e2871. doi: 10.1097/GOX.0000000000002871. eCollection 2020 Jun.

BACKGROUND: Problems with poor circulation often occur when a large defect or a distant region, such as the apex of the nose, is covered with a paramedian forehead flap. Delay technique increases the safety of reconstruction procedures, but it...

Cite
Itani Y, Yotsuyanagi T, Yamauchi M, et al. The Laterally Extended Paramedian Forehead Flap for Nasal Reconstruction: The Delay Technique Revisited. Plast Reconstr Surg Glob Open. 2020;8(6):e2871doi: 10.1097/GOX.0000000000002871.
Itani, Y., Yotsuyanagi, T., Yamauchi, M., Sugai, A., Kato, S., Yamashita, K., & Isogai, N. (2020). The Laterally Extended Paramedian Forehead Flap for Nasal Reconstruction: The Delay Technique Revisited. Plastic and reconstructive surgery. Global open, 8(6), e2871. https://doi.org/10.1097/GOX.0000000000002871
Itani, Yoshihito, et al. "The Laterally Extended Paramedian Forehead Flap for Nasal Reconstruction: The Delay Technique Revisited." Plastic and reconstructive surgery. Global open vol. 8,6 (2020): e2871. doi: https://doi.org/10.1097/GOX.0000000000002871
Itani Y, Yotsuyanagi T, Yamauchi M, Sugai A, Kato S, Yamashita K, Isogai N. The Laterally Extended Paramedian Forehead Flap for Nasal Reconstruction: The Delay Technique Revisited. Plast Reconstr Surg Glob Open. 2020 Jun 15;8(6):e2871. doi: 10.1097/GOX.0000000000002871. eCollection 2020 Jun. PMID: 32766039; PMCID: PMC7339298.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 82 entries